According to Perkins and Will and the nonprofit Healthy Building Network, building products with antimicrobial treatments are not proved to be a safe or effective means of controlling the spread of COVID-19.
The two organizations issued a statement reaffirming the conclusion of their March 2017 white paper on antimicrobial building products: Antimicrobial additives have not been proven to have the health benefits they promote, and alternatives should be sought wherever possible. No scientific evidence exists that demonstrates any health benefits from antimicrobial additives in building products and materials. “There is no evidence that the addition of antimicrobials to building products lowers the rate of infection or that they lead to a healthier population,” said Teresa McGrath, HBN Chief Research Officer and Toxicologist. These products include textile, furnishings, flooring, tiles, and other surfaces and interior finishes.
It is quite the contrary, in fact, as evidence suggests that with repeated human exposure, antimicrobials can inadvertently contribute to the formation of “super bugs” that are resistant to medical treatment. Antimicrobial additives have also been shown to leach out of materials during use and enter drains and water treatment facilities. Some antimicrobials, such as nano silver, are considered toxic to humans and entire aquatic ecosystems. Another issue with antimicrobial products is that they can create a false sense of security, which may lead to a reduced role of proper cleaning and less-diligent facility maintenance.
Related Stories
Healthcare Facilities | Sep 8, 2023
Modern healthcare interiors: Healing and care from the outside in
CO Architects shares design tips for healthcare interiors, from front desk to patient rooms.
Codes and Standards | Jul 19, 2023
Office leasing in major markets by financial services firms rebounds to pre-pandemic norms
Though the pandemic led to reductions in office leasing by financial services firms in gateway markets, a recent report by JLL found a notable leasing resurgence by those firms.
Multifamily Housing | Jun 29, 2023
5 ways to rethink the future of multifamily development and design
The Gensler Research Institute’s investigation into the residential experience indicates a need for fresh perspectives on residential design and development, challenging norms, and raising the bar.
Office Buildings | Jun 28, 2023
When office-to-residential conversion works
The cost and design challenges involved with office-to-residential conversions can be daunting; designers need to devise creative uses to fully utilize the space.
Arenas | May 18, 2023
How can we reimagine live sports experiences?
A Gensler survey finds what sports fans' experiences have been like returning to arenas, and their expectations going forward.
Headquarters | May 15, 2023
The new definition of Class A property
Dan Cheetham, Managing Director and Founder of FYOOG, believes organizations returning to a "hub and spoke" model could have a profound effect on properties once considered Class B.
Office Buildings | May 5, 2023
9 workplace design trends for 2023
HOK Director of WorkPlace Kay Sargent and Director of Interiors Tom Polucci discuss the trends shaping office design in 2023.
Multifamily Housing | Apr 4, 2023
Acing your multifamily housing amenities for the modern renter
Eighty-seven percent of residents consider amenities when signing or renewing a lease. Here are three essential amenity areas to focus on, according to market research and trends.
Urban Planning | Mar 16, 2023
Three interconnected solutions for 'saving' urban centers
Gensler Co-CEO Andy Cohen explores how the global pandemic affected city life, and gives three solutions for revitalizing these urban centers.
Laboratories | Mar 9, 2023
5 laboratory design choices that accelerate scientific discovery
Stephen Blair, director of CannonDesign's Science & Technology Practice, identifies five important design strategies to make the most out of our research laboratories.
